Rapidly progressive dementia and severe awake bruxism resistance to treatment: An unresolved challenge to treatment

	Rapidly progressive dementia and severe awake bruxism resistance to treatment: An unresolved challenge to treatment
Advances in Pharmacology and Therapeutics Journal
Article 1, Volume 1, Issue 2, December 2021, Pages 52-57 PDF (224.58 K)
Document Type: Case study
DOI: 10.18502/aptj.v1i2.8669
Authors
Reza Bidaki; zahra Alizadeh; Milad Sadeghi; Ali Zare^*
Abstract
Background: Bruxism is a chief complaint in some patients with dementia, but there is no clear guideline for its management.Here, we presented a case with awake bruxism. Case presentation: This case report study described an 88-year-old woman with severe rapidly progressive dementia (RPD) and awake bruxism, which was improved with discontinuation of sertraline, quetiapine, gabapentin, and resumption of trazodone. Conclusion: In this case study, despite taking drugs from different classifications for bruxism treatment, no improvement was seen. Bruxism is an important and challenging condition for physicians and caregivers in dementia patients. Although bruxism needs serious treatment, there is no suitable and well-defined treatment for this disorder. Further studies are needed to suggest an efficient drug for the management of bruxism.
Keywords
Bruxism; Dementia; Resistance to treatment

Statistics Article View: 261 PDF Download: 2,042